OGAWA Kazuei

写真a

Title

Professor

Current Affiliation Organization 【 display / non-display

  • Duty ,  Fukushima Medical University ,  Preparing Section for New Faculty of Medical Science ,  Professor

  • Concurrently ,  School of Medicine (Clinical Medicin) ,  Department of Hematology ,  Professor

Field of expertise (Grants-in-aid for Scientific Research classification) 【 display / non-display

  • Hematology

  • Hematology

  • Regenerative Therapy

  • Leukemia Cell Study

 

Research Career 【 display / non-display

  • Regenerative therapy

  • Leukemia cell study

Papers 【 display / non-display

  • Steroid-resistant autoimmune myelofibrosis in a patient with autoimmune hepatitis and Evans syndrome complicated with increased expression of TGF-β in the bone marrow: a case report

    Hiroshi Ohkawara, Miki Furukawa, Kazuhiko Ikeda, Akiko Shichishima-Nakamura, Masahiko Fukatsu, Takahiro Sano, Koki Ueda, Satoshi Kimura, Risa Kanai, Yuka Oka, Fumi Murakami, Osamu Suzuki, Yuko Hashimoto, Kazuei Ogawa, Takayuki Ikezoe

    International Journal of Hematology ,  106 (5) 718 - 724 ,  2017.11

    Multiple Authorship

  • The amelioration of myelofibrosis with thrombocytopenia by a JAK1/2 inhibitor, ruxolitinib, in a post-polycythemia vera myelofibrosis patient with a JAK2 Exon 12 mutation

    Ikeda Kazuhiko, Ueda Koki, Sano Takahiro, Ogawa Kazuei, Ikezoe Takayuki, Hashimoto Yuko, Morishita Soji, Komatsu Norio, Ohto Hitoshi, Takeishi Yasuchika

    Internal Medicine ,  56 (13) 1705 - 1710 ,  2017.07

    Multiple Authorship

    DOI

  • Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms

    Koki Ueda, Kazuhiko Ikeda, Takayuki Ikezoe, Kayo Harada-Shirado, Kazuei Ogawa, Yuko Hashimoto, Takahiro Sano, Hiroshi Ohkawara, Satoshi Kimura, Akiko Shichishima-Nakamura, Yuichi Nakamura, Yayoi Shikama, Tsutomu Mori, Philip J. Mason, Monica Bessler, Soji Morishita, Norio Komatsu, Kotaro Shide, Kazuya Shimoda, Shuhei Koide, Kazumasa Aoyama, Motohiko Oshima, Atsushi Iwama, Yasuchika Takeishi

    blood advances ,  1 (15) 1001 - 1015 ,  2017.06

    Multiple Authorship

  • Autocrine and paracrine interactions between multiple myeloma cells and bone marrow stromal cells by growth arrest-specific gene 6 cross-talk with interleukin-6

    Miki Furukawa, Hiroshi Ohkawara, Kazuei Ogawa, Kazuhiko Ikeda, Koki Ueda, Akiko Shichishima-Nakamura, Emi Ito, Jun-ichi Imai, Yuka Yanagisawa, Reiko Honma, Shinya Watanabe, Satoshi Waguri, Takayuki Ikezoe, Yasuchika Takeishi

    Journal of Biological Chemistry ,  292 (10) 4280 - 4292 ,  2017.03

    Multiple Authorship

  • A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation

    Masahiko Fukatsu, Takenobu Murakami, Hiroshi Ohkawara, Shunichi Saito, Kazuhiko Ikeda, Suguru Kadowaki, Itaru Sasaki, Mari Segawa, Tomoko Soeda, Akihiko Hoshi, Hiroshi Takahashi, Akihiko Shichishima-Nakamura, Kazuei Ogawa, Yoshihiro Sugita, Hitoshi Ohto, Yasuchika Takeishi, Takayuki Ikezoe, Yoshikazu Ugawa

    BMC Neurology ,  17 (1) 93 ,  2017

    Multiple Authorship

display all >>

Presentations 【 display / non-display

  • HMGA2 orchestrates the tumorgenesis of myeloproliferative neoplasms (MPN) in corporation with JAK2V617F

    58th American Society of Hematology (ASH) Annual Meeting and Exposition , 

    2016.12
     
     

  • The role of oncogene HMGA2 in the pathogenesis of myeloproliferative neoplasms (MPN)

    第78回 日本血液学会学術集会 , 

    2016.10
     
     

  • The role of oncogene HMGA2 in the pathogenesis of myeloproliferative neoplasms (MPN)

    第78回 日本血液学会学術集会−第3回Scientific Exchange Training Program (SETP) , 

    2016.10
     
     

  • Autocrine and paracrine interactions by Gas 6 signaling pathways via IL-6 between MM cells and BMSCs

    第78回 日本血液学会学術集会 , 

    2016.10
     
     

  • The role of HMGA2 in the pathogenesis of myeloproliferative neoplasms (MPNs)

    The 5th JCA-AACR Special Joint Conference “The Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics” , 

    2016.07
     
     

display all >>